Oncology Expertise

Oncology Expertise

The team of Landmark Research ensures excellence across all phases of clinical development, from first-in-human studies to large-scale pivotal trials and real-world evidence generation.

Overview

With experience spanning chemotherapy, immunotherapy, targeted therapy, radiotherapy, and supportive care products, we deliver strategies that align with global oncology standards while keeping patient safety, quality of life, and survival at the forefront.

Our comprehensive oncology research approach covers all therapeutic modalities and treatment combinations. We focus on delivering evidence that supports improved survival outcomes, enhanced quality of life, and meaningful patient experiences while ensuring compliance with international oncology research standards and regulatory requirements.

Comprehensive Clinical Trials

Specialized design and execution for oncology drugs, biologics, devices, and combination therapies

Regulatory Excellence

Expertise in oncology-specific regulatory pathways, orphan drug approvals, and accelerated access programs

Patient-Centric Research

Emphasis on quality of life, symptom management, and survivorship alongside clinical efficacy

Outcome-Driven Insights

Generation of meaningful endpoints, including progression-free survival, overall survival, and patient-reported outcomes

Our Capabilities

Regulatory Expertise

Preparation of dossiers, CERs, and submissions fully aligned with oncology-focused regulatory pathways.

Patient-Centric Approach

Engaging with patients and physicians to ensure high recruitment and retention in long-term oncology studies.

Innovative Analytics

Use of advanced biostatistics and AI-driven biomarker analysis for faster, more reliable oncology outcomes.

Landmark CRO
Go Back Top